表紙:サイコバイオティクスの市場予測・競合動向・成長機会 (~2026年):タイプ・向精神薬タイプ・形態・流通経路・用途・地域別
市場調査レポート
商品コード
1025678

サイコバイオティクスの市場予測・競合動向・成長機会 (~2026年):タイプ・向精神薬タイプ・形態・流通経路・用途・地域別

Global Psychobiotics Market, By Type, By Psychotropic Agent, By Form, By Distribution Channel, By Application, By Region, Competition Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.75円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

サイコバイオティクスの市場予測・競合動向・成長機会 (~2026年):タイプ・向精神薬タイプ・形態・流通経路・用途・地域別
出版日: 2021年09月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のサイコバイオティクスの市場は、うつ病や不安症などの心理的疾患に対するプロバイオティクスの需要が高まっていることから、成長が見込まれています。

うつ病や不安症の患者数の増加も今後5年間の市場成長を牽引する見通しです。身体的な健康だけでなく、精神的な健康にも関心を持つ消費者が急速に増加しています。健康意識の高い消費者は、サイコバイオティクスを積極的に利用し、日々の食生活に取り入れており、今後5年間の成長を支える見通しです。

当レポートでは、世界のサイコバイオティクスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、顧客の声の分析、特許動向、臨床試験の動向、市場規模の推移・予測、タイプ・向精神薬タイプ・形態・流通経路・用途別の内訳、地域・主要国別の詳細分析、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19の影響

第5章 顧客の声

第6章 世界市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
      • 食品サプリメント
      • 栄養補助食品
      • 特殊栄養素
      • 乳児用調製粉乳
    • 向精神薬タイプ別
      • レンサ球菌
      • ビフィズス菌
      • 乳酸桿菌
      • クロストリジウム
      • その他
    • 形態別
      • 粉末
      • 液体/流体
      • 錠剤
    • 流通経路別
      • 小売店
      • ハイパーマーケット/スーパーマーケット
      • ドラッグストア/薬局
      • オンライン
    • 用途別
      • 胃腸機能
      • 抗うつ薬
      • 抗不安薬
      • 自閉症スペクトラム障害
      • 注意欠陥多動性障害
      • 統合失調症
      • その他
    • 企業別
    • 地域別
  • 製品市場マップ

第7章 北米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • 向精神薬タイプ別
    • 形態別
    • 流通経路別
    • 用途別
    • 国別

第8章 欧州市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • 向精神薬タイプ別
    • 形態別
    • 流通経路別
    • 用途別
    • 国別

第9章 アジア太平洋市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • 向精神薬タイプ別
    • 形態別
    • 流通経路別
    • 用途別
    • 国別

第10章 南米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • 向精神薬タイプ別
    • 形態別
    • 流通経路別
    • 用途別
    • 国別

第11章 中東・アフリカ市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • 向精神薬タイプ別
    • 形態別
    • 流通経路別
    • 用途別
    • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向

第14章 臨床試験

第15章 特許分析

第16章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • InnovixLabs
    • Bened Biomedical Co., Ltd
    • Nutrimmun GmbH
    • Kerry Group Plc.
    • Sabinsa Corporation
    • Lallemand Health Solutions Inc.
    • DuPont de Nemours, Inc.
    • Uplift Food Pty Ltd.
    • Nature's Bounty Co. Ltd.
    • BioGaia Group
    • The Life Extension Foundation
    • Lifted Naturals

第17章 戦略的提言

第16章 当社について&免責事項

目次
Product Code: 7678

The growth of Global psychobiotics market in the forecast period, 2022-2026 can be attributed to the rising demand of the probiotics for the psychological ailments like depression and anxiety. Additionally, rising instances of depression and anxiety among the population at large is driving the growth of the global psychobiotics market in the next five years. Moreover, the number of consumers concerned about mental health as well as physical health is rapidly increasing. The consumers are concerned about the over the counter available psychobiotics drugs that may or may not cause adverse effects on the consumers' physical health. Mental illness is also rapidly affecting the population, especially the young population. Health conscious and woke population is actively utilizing the availability of these psychobiotics and incorporating them in their daily food routines, thereby supporting the growth of the global psychobiotics market in the upcoming five years.

The global psychobiotics market is segmented by type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution. Based on type, the market is further segmented into food supplements, nutritional supplements, specialty nutrients, and infant formula. Nutritional supplements are anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly growing number of consumers inclined toward self-medication. The consumers are eagerly adapting the psychobiotics as a nutritional supplement for healthy brain. Large population is suffering from depression, stress and anxiety. The tendency of self-diagnosing and self-medication is very active among the young population and thus they are aiding to the growth of the global psychobiotics market in the upcoming five years forecast, until 2026.

Holding the major shares of the global psychobiotics market are Innovix Labs, Bened Biomedical Co., Ltd, Nutrimmun GmbH, Kerry Group Plc., Sabinsa Corporation, Lallemand Health Solutions Inc., DuPont de Nemours, Inc., Uplift Food Pty Ltd., Nature's Bounty Co. Ltd., BioGaia Group, The Life Extension Foundation, Lifted Naturals, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through psychobiotics. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global psychobiotics market from 2016 to 2019.
  • To estimate and forecast the market size of global psychobiotics market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global psychobiotics market based on type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global psychobiotics market.
  • To identify drivers and challenges for global psychobiotics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global psychobiotics market.
  • To identify and analyze the profile of leading players operating in global psychobiotics market.
  • To identify key sustainable strategies adopted by market players in global psychobiotics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global psychobiotics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributors and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to psychobiotics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global psychobiotics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Psychobiotics Market, By Type:

Food Supplements

Nutritional Supplements

Specialty Nutrients

Infant Formula

  • Global Psychobiotics Market, By Psychotropic Agents:

Streptococcus

Bifidobacterium

Lactobacillus

Clostridium

Others

  • Global Psychobiotics Market, By Form:

Powder

Liquid/ Fluid

Tablets

  • Global Psychobiotics Market, By Distribution Channel:

Retail Shops

Hypermarkets/ Supermarkets

Drug Store/ Pharmacy

Online

  • Global Psychobiotics Market, By Application:

Gastrointestinal Function

Antidepressant

Anxiolytic

Autism Spectrum Disorder

Attention Deficit Hyperactivity Disorder

Schizophrenia

Others

  • Global Psychobiotics Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Slovakia
  • Poland
  • Sweden

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Taiwan

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global psychobiotics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Psychobiotics Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Preferred Mode of Purchase
  • 5.3. Major Factors Contributing to Mental Illness
  • 5.4. Willingness towards Psychobiotics Consumption
  • 5.5. Commonly Observed Psychological Effect Post Consumption

6. Global Psychobiotics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula)
    • 6.2.2. By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others)
    • 6.2.3. By Form (Powder, Liquid/Fluid, Tablets)
    • 6.2.4. By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online)
    • 6.2.5. By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Psychobiotics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Psychotropic Agent
    • 7.2.3. By Form
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Psychobiotics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Psychotropic Agent
        • 7.3.1.2.3. By Form
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By Application
    • 7.3.2. Mexico Psychobiotics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Psychotropic Agent
        • 7.3.2.2.3. By Form
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By Application
    • 7.3.3. Canada Psychobiotics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Psychotropic Agent
        • 7.3.3.2.3. By Form
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By Application

8. Europe Psychobiotics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Psychotropic Agent
    • 8.2.3. By Form
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Psychobiotics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Psychotropic Agent
        • 8.3.1.2.3. By Form
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By Application
    • 8.3.2. Germany Psychobiotics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Psychotropic Agent
        • 8.3.2.2.3. By Form
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By Application
    • 8.3.3. United Kingdom Psychobiotics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Psychotropic Agent
        • 8.3.3.2.3. By Form
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By Application
    • 8.3.4. Italy Psychobiotics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Psychotropic Agent
        • 8.3.4.2.3. By Form
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By Application
    • 8.3.5. Spain Psychobiotics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Psychotropic Agent
        • 8.3.5.2.3. By Form
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By Application
    • 8.3.6. Sweden Psychobiotics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Psychotropic Agent
        • 8.3.6.2.3. By Form
        • 8.3.6.2.4. By Distribution Channel
        • 8.3.6.2.5. By Application
    • 8.3.7. Poland Psychobiotics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Type
        • 8.3.7.2.2. By Psychotropic Agent
        • 8.3.7.2.3. By Form
        • 8.3.7.2.4. By Distribution Channel
        • 8.3.7.2.5. By Application
    • 8.3.8. Slovakia Psychobiotics Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Type
        • 8.3.8.2.2. By Psychotropic Agent
        • 8.3.8.2.3. By Form
        • 8.3.8.2.4. By Distribution Channel
        • 8.3.8.2.5. By Application

9. Asia-Pacific Psychobiotics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Psychotropic Agent
    • 9.2.3. By Form
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Psychobiotics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Psychotropic Agent
        • 9.3.1.2.3. By Form
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By Application
    • 9.3.2. India Psychobiotics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Psychotropic Agent
        • 9.3.2.2.3. By Form
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By Application
    • 9.3.3. South Korea Psychobiotics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Psychotropic Agent
        • 9.3.3.2.3. By Form
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By Application
    • 9.3.4. Japan Psychobiotics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Psychotropic Agent
        • 9.3.4.2.3. By Form
        • 9.3.4.2.4. By Distribution Channel
        • 9.3.4.2.5. By Application
    • 9.3.5. Australia Psychobiotics Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Psychotropic Agent
        • 9.3.5.2.3. By Form
        • 9.3.5.2.4. By Distribution Channel
        • 9.3.5.2.5. By Application
    • 9.3.6. Taiwan Psychobiotics Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Type
        • 9.3.6.2.2. By Psychotropic Agent
        • 9.3.6.2.3. By Form
        • 9.3.6.2.4. By Distribution Channel
        • 9.3.6.2.5. By Application
    • 9.3.7. Malaysia Psychobiotics Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Type
        • 9.3.7.2.2. By Psychotropic Agent
        • 9.3.7.2.3. By Form
        • 9.3.7.2.4. By Distribution Channel
        • 9.3.7.2.5. By Application
    • 9.3.8. Singapore Psychobiotics Market Outlook
      • 9.3.8.1. Market Size & Forecast
        • 9.3.8.1.1. By Value
      • 9.3.8.2. Market Share & Forecast
        • 9.3.8.2.1. By Type
        • 9.3.8.2.2. By Psychotropic Agent
        • 9.3.8.2.3. By Form
        • 9.3.8.2.4. By Distribution Channel
        • 9.3.8.2.5. By Application

10. South America Psychobiotics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Psychotropic Agent
    • 10.2.3. By Form
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Psychobiotics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Psychotropic Agent
        • 10.3.1.2.3. By Form
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By Application
    • 10.3.2. Argentina Psychobiotics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Psychotropic Agent
        • 10.3.2.2.3. By Form
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By Application
    • 10.3.3. Colombia Psychobiotics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Psychotropic Agent
        • 10.3.3.2.3. By Form
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By Application

11. Middle East and Africa Psychobiotics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Psychotropic Agent
    • 11.2.3. By Form
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Application
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Psychobiotics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Psychotropic Agent
        • 11.3.1.2.3. By Form
        • 11.3.1.2.4. By Distribution Channel
        • 11.3.1.2.5. By Application
    • 11.3.2. Saudi Arabia Psychobiotics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Psychotropic Agent
        • 11.3.2.2.3. By Form
        • 11.3.2.2.4. By Distribution Channel
        • 11.3.2.2.5. By Application
    • 11.3.3. UAE Psychobiotics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Psychotropic Agent
        • 11.3.3.2.3. By Form
        • 11.3.3.2.4. By Distribution Channel
        • 11.3.3.2.5. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Patent Analysis

16. Competitive Landscape

  • 16.1. Competition Outlook
  • 16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 16.2.1. InnovixLabs
    • 16.2.2. Bened Biomedical Co., Ltd
    • 16.2.3. Nutrimmun GmbH
    • 16.2.4. Kerry Group Plc.
    • 16.2.5. Sabinsa Corporation
    • 16.2.6. Lallemand Health Solutions Inc.
    • 16.2.7. DuPont de Nemours, Inc.
    • 16.2.8. Uplift Food Pty Ltd.
    • 16.2.9. Nature's Bounty Co. Ltd.
    • 16.2.10. BioGaia Group
    • 16.2.11. The Life Extension Foundation
    • 16.2.12. Lifted Naturals

17. Strategic Recommendations

18. About Us & Disclaimer